SUSQUEHANNA INTERNATIONAL GROUP, LLP - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is and the CUSIP is 00444T209. A total of 32 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$70,287
+81.1%
121,185
+246.7%
0.00%
Q2 2023$38,803
+107.0%
34,958
+23.1%
0.00%
Q1 2023$18,744
-86.9%
28,400
-55.3%
0.00%
Q4 2022$143,63263,5540.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CANTOR FITZGERALD, L. P. 7,050$3,029,1030.08%
Nantahala Capital Management 1,173,015$680,3490.06%
Values First Advisors, Inc. 122,465$71,0300.05%
Nantahala Capital Management 755,000$437,9000.04%
TANG CAPITAL MANAGEMENT LLC 195,000$113,1000.02%
CANTOR FITZGERALD, L. P. 705,000$408,9000.01%
Rock Springs Capital Management LP 316,460$183,5470.01%
COWEN AND COMPANY, LLC 115,657$67,0810.01%
Virtu Financial LLC 25,641$150.00%
VANGUARD GROUP INC 171,791$99,6390.00%
View complete list of ACELRX PHARMACEUTICALS INC shareholders